Symposia: Acute Lymphoblastic Leukemias: Biomarkers, Molecular Markers, and Minimal Residual Disease in Diagnosis and Prognosis
Program: Oral and Poster Abstracts
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Fundamental Science, Apoptosis, Adult, Clinical Practice (Health Services and Quality), Translational Research, Epidemiology, Genetic Disorders, Genomics, Bioinformatics, Chimeric Antigen Receptor (CAR)-T Cell Therapies, CML, Clinical Research, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Treatment Considerations, Biological therapies, Immunology, Clinical procedures, Adverse Events, Lymphoid Malignancies, Computational biology, Biological Processes, Myeloid Malignancies, Technology and Procedures, Study Population, Profiling, Human, Pathogenesis, Measurable Residual Disease , Molecular testing, Omics technologies, Pathology
Type: Poster
Hematology Disease Topics & Pathways:
Research, Lymphoid Leukemias, ALL, Fundamental Science, Apoptosis, Adult, Clinical Practice (Health Services and Quality), Translational Research, Epidemiology, Genetic Disorders, Genomics, Bioinformatics, Chimeric Antigen Receptor (CAR)-T Cell Therapies, CML, Clinical Research, Chronic Myeloid Malignancies, Health disparities research, Pediatric, Diseases, Treatment Considerations, Biological therapies, Immunology, Clinical procedures, Adverse Events, Lymphoid Malignancies, Computational biology, Biological Processes, Myeloid Malignancies, Technology and Procedures, Study Population, Profiling, Human, Pathogenesis, Measurable Residual Disease , Molecular testing, Omics technologies, Pathology
Sunday, December 8, 2024: 6:00 PM-8:00 PM
Halls G-H
(San Diego Convention Center)
See more of: Oral and Poster Abstracts
*signifies non-member of ASH